Approval · Notice of Compliance 31902 · 2023
TARGIN: Notice of Compliance 31902
Issued October 19, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31902
- Date
- October 19, 2023
- Company
- Purdue PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety update to the Product Monograph (PM) and conversion to the 2020 Master Template.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TARGIN | Not yet assigned | — |
Medicinal ingredients
- NALOXONE HYDROCHLORIDE 2.5 MG per TAB
- OXYCODONE HYDROCHLORIDE 5 MG per TAB
- NALOXONE HYDROCHLORIDE 5 MG per TAB
- OXYCODONE HYDROCHLORIDE 10 MG per TAB
- NALOXONE HYDROCHLORIDE 10 MG per TAB
- OXYCODONE HYDROCHLORIDE 20 MG per TAB
- NALOXONE HYDROCHLORIDE 20 MG per TAB
- OXYCODONE HYDROCHLORIDE 40 MG per TAB